These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33193581)

  • 1. MicroRNAs in Podocyte Injury in Diabetic Nephropathy.
    Ishii H; Kaneko S; Yanai K; Aomatsu A; Hirai K; Ookawara S; Ishibashi K; Morishita Y
    Front Genet; 2020; 11():993. PubMed ID: 33193581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of miRNA-155 Alleviates High Glucose-Induced Podocyte Inflammation by Targeting SIRT1 in Diabetic Mice.
    Wang X; Gao Y; Yi W; Qiao Y; Hu H; Wang Y; Hu Y; Wu S; Sun H; Zhang T
    J Diabetes Res; 2021; 2021():5597394. PubMed ID: 33748285
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Liu X; Jiang L; Zeng H; Gao L; Guo S; Chen C; Liu X; Zhang M; Ma L; Li Y; Qi X; Wu Y
    Autophagy; 2024 May; 20(5):1072-1097. PubMed ID: 38050963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-503 contributes to podocyte injury via targeting E2F3 in diabetic nephropathy.
    Zha F; Bai L; Tang B; Li J; Wang Y; Zheng P; Ji T; Bai S
    J Cell Biochem; 2019 Aug; 120(8):12574-12581. PubMed ID: 30834596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-4645-3p attenuates podocyte injury and mitochondrial dysfunction in diabetic kidney disease by targeting Cdk5.
    Zhang Y; Xia S; Tian X; Yuan L; Gao Y; Liu D; Qi H; Wang S; Liu Z; Li Y; Zhao Z; Liu W
    FASEB J; 2024 May; 38(10):e23668. PubMed ID: 38742811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D/VDR Protects Against Diabetic Kidney Disease by Restoring Podocytes Autophagy.
    Song Z; Xiao C; Jia X; Luo C; Shi L; Xia R; Zhu J; Zhang S
    Diabetes Metab Syndr Obes; 2021; 14():1681-1693. PubMed ID: 33889003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA SNHG5 promotes podocyte injury via the microRNA-26a-5p/TRPC6 pathway in diabetic nephropathy.
    Zhou Y; Li ZL; Ding L; Zhang XJ; Liu NC; Liu SS; Wang YF; Ma RX
    J Biol Chem; 2022 Dec; 298(12):102605. PubMed ID: 36257404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-1187 induces podocyte injury and diabetic nephropathy through autophagy.
    Chen B; He Q
    Diab Vasc Dis Res; 2023; 20(3):14791641231172139. PubMed ID: 37208852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progranulin alleviates podocyte injury via regulating CAMKK/AMPK-mediated autophagy under diabetic conditions.
    Zhou D; Zhou M; Wang Z; Fu Y; Jia M; Wang X; Liu M; Zhang Y; Sun Y; Zhou Y; Lu Y; Tang W; Yi F
    J Mol Med (Berl); 2019 Nov; 97(11):1507-1520. PubMed ID: 31402399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury.
    Wang Y; Feng F; He W; Sun L; He Q; Jin J
    Bioengineered; 2022 Jan; 13(1):774-788. PubMed ID: 34847832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MALAT1/microRNA let-7f/KLF5 axis regulates podocyte injury in diabetic nephropathy.
    Zhang H; Yan Y; Hu Q; Zhang X
    Life Sci; 2021 Feb; 266():118794. PubMed ID: 33232688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
    Zhang L; Li R; Shi W; Liang X; Liu S; Ye Z; Yu C; Chen Y; Zhang B; Wang W; Lai Y; Ma J; Li Z; Tan X
    Br J Pharmacol; 2013 Sep; 170(2):426-39. PubMed ID: 23826864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAD2B promotes podocyte injury through regulating Numb-dependent Notch 1 pathway in diabetic nephropathy.
    Li MR; Lei CT; Tang H; Yin XJ; Hao Z; Qiu Y; Xie YR; Zeng JY; Su H; Zhang C
    Int J Biol Sci; 2022; 18(5):1896-1911. PubMed ID: 35342338
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrated Network Pharmacology and Cellular Assay to Explore the Mechanisms of Selenized Tripterine Phytosomes (Se@Tri-PTs) Alleviating Podocyte Injury in Diabetic Nephropathy.
    Zhu S; Liu Q; Chang Y; Luo C; Zhang X; Sun S
    Curr Pharm Des; 2023; 29(38):3073-3086. PubMed ID: 37961864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone modification in podocyte injury of diabetic nephropathy.
    Wang S; Zhang X; Wang Q; Wang R
    J Mol Med (Berl); 2022 Oct; 100(10):1373-1386. PubMed ID: 36040515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy.
    Gao J; Liang Z; Zhao F; Liu X; Ma N
    Bioengineered; 2022 May; 13(5):12275-12288. PubMed ID: 35603354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy.
    Zhou Z; Wan J; Hou X; Geng J; Li X; Bai X
    Cell Death Dis; 2017 Mar; 8(3):e2658. PubMed ID: 28277542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of microRNAs in renal disorders related to primary podocyte dysfunction.
    Iranzad R; Motavalli R; Ghassabi A; Pourakbari R; Etemadi J; Yousefi M
    Life Sci; 2021 Jul; 277():119463. PubMed ID: 33862110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.